v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 27, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 19.9 $ 8.3
Restricted cash 2.3 2.4
Accounts and other receivables, net of allowances of $0.4 and $0.5, respectively 62.7 50.0
Prepayments and accrued income 7.2 5.4
Inventories 98.9 92.4
Current assets held-for-sale 0.0 5.5
Total current assets 191.0 164.0
Non-current assets    
Property, plant and equipment, net 61.3 60.2
Right-of-use assets from operating leases 9.3 8.5
Goodwill 68.8 69.6
Intangibles, net 10.3 10.9
Deferred tax assets 1.2 1.2
Pensions and other retirement benefits 41.0 54.9
Investments and loans to joint ventures and other affiliates 0.4 0.4
Total assets 383.3 369.7
Current liabilities    
Current maturities of long-term debt and short-term borrowings 0.0 25.0
Accounts payable 22.0 24.6
Accrued liabilities 34.6 27.2
Taxes on income 5.8 2.6
Current liabilities held-for-sale 0.0 2.8
Other current liabilities 14.9 16.0
Total current liabilities 77.3 98.2
Non-current liabilities    
Long-term debt 57.7 14.4
Pensions and other retirement benefits 0.1 0.1
Deferred tax liabilities 14.9 18.4
Other non-current liabilities 11.4 12.2
Total liabilities 161.4 143.3
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary shares of £0.50 par value; authorized 40,000,000 shares for 2026 and 2025; issued 28,944,000 for 2026 and 2025; outstanding 26,759,711 and 26,640,434 for 2026 and 2025, respectively 26.5 26.5
Additional paid-in capital 229.1 228.7
Treasury shares (28.6) (27.6)
Company shares held by ESOP (0.5) (0.7)
Retained earnings 101.5 102.5
Accumulated other comprehensive loss (106.1) (103.0)
Total shareholders' equity 221.9 226.4
Total liabilities and shareholders' equity $ 383.3 $ 369.7